Liberum Capital Analysts Give Roche Holding Ltd. (ROG) a CHF 279 Price Target

Roche Holding Ltd. (VTX:ROG) has been assigned a CHF 279 price objective by Liberum Capital in a research report issued on Wednesday. The firm currently has a “buy” rating on the healthcare company’s stock. Liberum Capital’s price objective would suggest a potential upside of 13.41% from the stock’s current price.

A number of other equities analysts also recently issued reports on the company. Baader Bank set a CHF 256 price target on Roche Holding and gave the stock a “buy” rating in a research report on Tuesday. HSBC Holdings PLC set a CHF 205 target price on Roche Holding and gave the company a “sell” rating in a research report on Tuesday. Berenberg Bank set a CHF 260 target price on Roche Holding and gave the company a “neutral” rating in a research report on Monday. Goldman Sachs Group, Inc. (The) set a CHF 325 price target on Roche Holding and gave the company a “buy” rating in a report on Monday. Finally, Morgan Stanley set a CHF 260 price target on Roche Holding and gave the company a “neutral” rating in a report on Friday, November 17th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have assigned a buy rating to the stock. Roche Holding currently has an average rating of “Hold” and an average target price of CHF 261.78.

Roche Holding (VTX:ROG) opened at CHF 246 on Wednesday. Roche Holding has a 1 year low of CHF 218.30 and a 1 year high of CHF 273.

COPYRIGHT VIOLATION WARNING: “Liberum Capital Analysts Give Roche Holding Ltd. (ROG) a CHF 279 Price Target” was originally posted by Transcript Daily and is owned by of Transcript Daily. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The legal version of this news story can be viewed at https://transcriptdaily.com/2017/11/22/liberum-capital-analysts-give-roche-holding-ltd-rog-a-chf-279-price-target.html.

Roche Holding Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply